# B-19 Parvovirus Vaccine Study

> **NCT00379938** · PHASE1,PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 43 (actual)

## Conditions studied

- Parvovirus B19 Infection

## Interventions

- **BIOLOGICAL:** VAI-VP705 (parvovirus B-19 vaccine)
- **DRUG:** Placebo
- **BIOLOGICAL:** MF-59

## Key facts

- **NCT ID:** NCT00379938
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2011-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00379938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00379938, "B-19 Parvovirus Vaccine Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00379938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*